Tenax Therapeutics share price logo

Tenax Therapeutics

NASDAQ: TENX

$1.36

-0.15

(-9.93%)

as on

Tenax Therapeutics Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.37
    $1.51
    downward going graph

    -0.74%

    Downside

    11.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.31
    $19.40
    downward going graph

    3.68%

    Downside

    1326.47%

    Upside

    downward going graph

Tenax Therapeutics share price movements today

Previous Close
$1.51
Open
$1.50
Volume
1.5M
Market Cap
$57.4M
Day's Low - High
$1.37 - $1.51
52 Week Low - High
$1.31 - $19.40

Tenax Therapeutics Historical Returns

1 Month Return
-17.03 %
3 Month Return
-89.99 %
1 Year Return
-77.86 %
3 Year Return
-93.81 %
5 Year Return
-99.95 %

Tenax Therapeutics Stock Fundamentals & Key Indicators

Check Tenax Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$57.4M

EPS (TTM)

-1.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.01

Industry PE ratio

-3.11

PEG Ratio

0.02

EBITDA

-65.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-61.55%

Tenax Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tenax Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$57.4M-99.95%-1.010.00%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Tenax Therapeutics Stock including INR - Dollar returns

The Tenax Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tenax Therapeutics investment value today

Current value as on today

₹21,549

Returns

-₹78,451

(-78.45%)

Returns from Tenax Therapeutics Stock

-₹80,059 (-80.06%)

Dollar Impact

₹1,608 (+1.61%)

Analyst Recommendation on Tenax Therapeutics Stock

Based on 4 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 4 analysts, 50% of analysts recommend a 'BUY' rating for Tenax Therapeutics. Average target price of $12.56

Tenax Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Tenax Therapeutics.

What analysts predicted

89.17%UPSIDE

Target Price

$12.56

Current Price

$1.36

Analyzed by

4 Analysts

High

$14

Target

$12.56

Low

$4

Tenax Therapeutics target price $12.56, a slight upside of 89.17% compared to current price of $1.36. According to 4 analysts rating.

Indian Investors' Interest in Tenax Therapeutics Stock

Search interest for Tenax Therapeutics Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Tenax Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-3
4
-7
-11
-11
-16
-16
-16
-18
EBITDA
-3
-3
-3
-6
-10
-10
-15
-15
-15
-18
Interest Expense
0
0
0
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-3
-3
-6
-10
-10
-15
-15
-15
-17
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-3
-6
-10
-10
-15
-15
-15
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tenax Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
-
-
-
-
-
Operating Income
-9
-6
-8
-9
-32
-11
-8
-19
-56
EBITDA
-9
-6
-8
-9
-32
-10
-7
-17
-52
Interest Expense
-
-
-
0
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
-
-
Income Before Tax
-8
-6
-8
-9
-32
-11
-7
-17
-52
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-8
-6
-8
-9
-32
-11
-7
-17
-52
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tenax Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-3
-3
-6
-10
-10
-15
37
-15
-17
Operating Cash Flow
-5
-3
-3
-3
-6
-6
-9
-13
-9
-14
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
7
0
92
0
23
0
3
11
30
13
Change in Cash
2
-3
88
-3
16
-5
-6
-1
21
0

Tenax Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-14
-8
-9
-32
-11
-7
-17
-52
Operating Cash Flow
-12
-5
-7
-9
-10
-12
-5
-14
-35
Investing Cash Flow
3
7
0
0
0
0
0
-
-
Financing Cash Flow
0
8
0
10
9
8
13
99
38
Change in Cash
-8
10
-7
1
0
-3
7
85
2

Global Institutional Holdings in Tenax Therapeutics

Check out the Institutions with significant holdings in Tenax Therapeutics.

Funds
Holdings
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
6.63%
Joseph Edelman
4.54%
iShares
3.64%
Vanguard
3.48%
Michael Rockefeller
1.42%

Tenax Therapeutics News & Key Events

  • img

    Today's Timeline - 31 August

    Mon, 07:20 PM

    -

    Guggenheim downgraded Tenax Therapeutics to Neutral from Buy, citing clinical and regulatory uncertainties despite potential trial insights.

Insights on Tenax Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 248.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 817.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TENX stock has moved down by -27.3%

About Tenax Therapeutics

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial hypertension. Founded in 1967, the organization was initially known as Oxygen Biotherapeutics, Inc. until its rebranding to Tenax Therapeutics, Inc. in September 2014. The company maintains its corporate headquarters in Morrisville, North Carolina.
OrganisationTenax Therapeutics
Headquarters101 Glen Lennox Drive, Chapel Hill, NC, 27517, US
IndustryBiotechnology
CEOChristopher T. Giordano

Key Management of Tenax Therapeutics

Name

Title

Dr. Douglas Hay Ph.D.

Executive Vice President of Regulatory Affairs

Mr. Timothy G. Healey M.B.A.

Chief Commercial Officer

Dr. So-Young Kim M.D.

Executive Vice President of Clinical Development & Strategy

Mr. Christopher T. Giordano

CEO, President & Director

Mr. Thomas A. McGauley

Principal Financial Officer & Principal Accounting Officer

Dr. Stuart Rich M.D.

Chief Medical Officer & Director

Mr. Thomas R. Staab II, CPA

Chief Financial Officer

Mr. Doug Randall

Chief Business Officer

FAQs

What is Tenax Therapeutics share price today?

Tenax Therapeutics share price today is $1.36 as on at the close of the market. Tenax Therapeutics share today touched a day high of $1.51 and a low of $1.37.

What is the 52 week high and 52 week low for Tenax Therapeutics share?

Tenax Therapeutics share touched a 52 week high of $19.40 on and a 52 week low of $1.31 on . Tenax Therapeutics stock price today i.e. is closed at $1.36,which is 92.99% down from its 52 week high and 3.82% up from its 52 week low.

What is Tenax Therapeutics's market capitalisation today?

Tenax Therapeutics market capitalisation is $0.00T as on .

How to invest in Tenax Therapeutics Stock (TENX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tenax Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Tenax Therapeutics Stock (TENX) from India?

Indian investors can start investing in Tenax Therapeutics (TENX) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Tenax Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Tenax Therapeutics share’s latest price of $1.36 as on October 17, 2026 at 8:46 am IST, you will get 7.3529 shares of Tenax Therapeutics. Learn more about fractional shares .

What are the returns that Tenax Therapeutics has given to Indian investors in the last 5 years?

Tenax Therapeutics stock has given -99.95% share price returns and 26.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?